Comprehensive Financial Consultants Institutional, Inc. Amgen Inc Transaction History

Comprehensive Financial Consultants Institutional, Inc.

$231 Million
Q1 2024

A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 4,729 shares of AMGN stock, worth $1.47 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

4,729

Previous 4,782 1.11%

Holding current value

$1.47 Million

Previous $1.38 Million 2.4%

% of portfolio

0.58%

Previous 0.65%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $14,250 - $17,201	-53 Reduced 1.11%	4,729 $1.34 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $15,342 - $17,307	60 Added 1.27%	4,782 $1.38 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $14,868 - $18,459	-68 Reduced 1.42%	4,722 $1.27 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $49,496 - $58,528	231 Added 5.07%	4,790 $1.06 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $67,511 - $82,284	299 Added 7.02%	4,559 $1.1 Million

Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $1,145 - $1,455	5 Added 0.12%	4,260 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $92,926 - $104,804	414 Added 10.78%	4,255 $1.08 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $5,075 - $5,648	-22 Reduced 0.57%	3,841 $948,000
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $37,275 - $41,236	-170 Reduced 4.22%	3,863 $914,000
Q4 2021 Mar 10, 2022	BUY	$198.88 - $227.6 $802,083 - $917,910	4,033 New	4,033 $915,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.

Account

Comprehensive Financial Consultants Institutional, Inc. Amgen Inc Transaction History